STAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-κB Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid Hormone
Open Access
- 1 July 1999
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 274 (27), 19301-19308
- https://doi.org/10.1074/jbc.274.27.19301
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Impaired intramembranous bone formation in connexin43 null miceBone, 1998
- Primary Hyperparathyroidism: To Lose BoneJournal of Bone and Mineral Research, 1997
- Distinct Roles for Leukemia Inhibitory Factor Receptor α-Chain and gp130 in Cell Type-specific Signal TransductionJournal of Biological Chemistry, 1997
- Two Signals Are Necessary for Cell Proliferation Induced by a Cytokine Receptor gp130: Involvement of STAT3 in Anti-ApoptosisImmunity, 1996
- Dominant Negative Stat3 Mutant Inhibits Interleukin-6-induced Jak-STAT Signal TransductionJournal of Biological Chemistry, 1996
- Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling PathwayCell, 1996
- STAT3 and STAT5B Are Targets of Two Different Signal Pathways Activated by Hematopoietin Receptors and Control Transcription via Separate Cytokine Response ElementsPublished by Elsevier BV ,1995
- Cytokine signal transductionCell, 1994
- The alphas, betas, and kinases of cytokine receptor complexesCell, 1993
- Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6Science, 1992